![Anders Fink Vadsholt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anders Fink Vadsholt
Corporate Officer/Principal en Alpha Healthcare Investments ApS .
Cargos activos de Anders Fink Vadsholt
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Alpha Healthcare Investments ApS
![]() Alpha Healthcare Investments ApS Miscellaneous Commercial ServicesCommercial Services Alpha Healthcare Investments ApS provides business and management consulting services. The private company is based in Virum, Denmark. | Corporate Officer/Principal | 01/01/2015 | - |
Obton Solenergi Sinope Komplementaranpartsselskab | Corporate Officer/Principal | 01/01/2015 | - |
Historial de carrera de Anders Fink Vadsholt
Antiguos cargos conocidos de Anders Fink Vadsholt.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ORPHAZYME A/S | Director/Miembro de la Junta | 29/06/2022 | 17/05/2023 |
Director Ejecutivo | 01/04/2022 | 01/10/2023 | |
Director Financiero/CFO | 01/05/2016 | 01/10/2023 | |
Contacto de Relaciones con Inversores | 01/05/2016 | 01/10/2023 | |
LEO Pharma A/S
![]() LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Director Ejecutivo | - | 01/01/2022 |
OxThera AB
![]() OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Director/Miembro de la Junta | 01/02/2019 | 01/01/2021 |
Lakeside Invest ApS
![]() Lakeside Invest ApS Financial ConglomeratesFinance Lakeside Invest ApS provides financial services. | Corporate Officer/Principal | 01/01/2015 | 01/01/2018 |
Copenhagen Innovation Capital Management ApS | Corporate Officer/Principal | 01/01/2015 | 01/01/2018 |
ZEALAND PHARMA A/S | Director/Miembro de la Junta | 21/10/2009 | 01/01/2010 |
Bankinvest Biomedical Venture
![]() Bankinvest Biomedical Venture Investment ManagersFinance Bankinvest Biomedical Venture provides investment services. The company was founded in 1998 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | 01/01/2010 | 01/01/2010 |
░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Formación de Anders Fink Vadsholt.
Copenhagen Business School | Graduate Degree |
University of Melbourne | Masters Business Admin |
Estadísticas
Internacional
Dinamarca | 12 |
Australia | 2 |
Suecia | 2 |
Operativa
Corporate Officer/Principal | 5 |
Director/Board Member | 4 |
Chief Executive Officer | 3 |
Sectorial
Health Technology | 7 |
Finance | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ZEALAND PHARMA A/S | Health Technology |
ORPHAZYME A/S | Health Technology |
Empresas privadas | 9 |
---|---|
Topotarget A/S
![]() Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Bankinvest Biomedical Venture
![]() Bankinvest Biomedical Venture Investment ManagersFinance Bankinvest Biomedical Venture provides investment services. The company was founded in 1998 and is headquartered in Copenhagen, Denmark. | Finance |
7TM A/S
![]() 7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Health Technology |
Alpha Healthcare Investments ApS
![]() Alpha Healthcare Investments ApS Miscellaneous Commercial ServicesCommercial Services Alpha Healthcare Investments ApS provides business and management consulting services. The private company is based in Virum, Denmark. | Commercial Services |
Lakeside Invest ApS
![]() Lakeside Invest ApS Financial ConglomeratesFinance Lakeside Invest ApS provides financial services. | Finance |
Obton Solenergi Sinope Komplementaranpartsselskab | |
Copenhagen Innovation Capital Management ApS | |
OxThera AB
![]() OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Health Technology |
LEO Pharma A/S
![]() LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
- Bolsa de valores
- Insiders
- Anders Fink Vadsholt
- Experiencia